Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice-Reference-Cited by-同舟云学术

Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice

Published:2017 Issue:1 Volume:32 Page:115
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Bae Kwi-Hyun¹²^ORCID,Seo Jung Beom¹,Jung Yun-A¹,Seo Hye-Young³,Kang Sun Hee⁴,Jeon Hui-Jeon²,Lee Jae Man⁵,Lee Sungwoo⁶,Kim Jung-Guk¹,Lee In-Kyu¹²,Jung Gwon-Soo¹,Park Keun-Gyu¹²^ORCID

Affiliation:

1. Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.

2. Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea.

3. Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.

4. Department of Surgery, Keimyung University School of Medicine, Daegu, Korea.

5. Department of Biochemistry and Cell Biology, Cell and Matrix Research Institute, Kyungpook National University School of Medicine, Daegu, Korea.

6. New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea.

Funder

Kyungpook National University Hospital

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.3803/EnM.2017.32.1.115

Reference34 articles.

1. Chronic kidney disease: the global challenge

2. Mechanisms of Tubulointerstitial Fibrosis

3. Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure

4. TGF-β: the master regulator of fibrosis

5. Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The modulation effects of plant‐derived bioactive ingredients on chronic kidney disease: Focus on the gut–kidney axis;Food Frontiers;2023-02

2. Protocol for a preclinical systematic review and meta-analysis of pharmacological targeting of peroxisome proliferator-activated receptors in experimental renal injury;BMJ Open Science;2021-11

3. Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway;Endocrinology and Metabolism;2021-10-31

4. Lobeglitazone attenuates fibrosis in corneal fibroblasts by interrupting TGF-beta-mediated Smad signaling;Graefe's Archive for Clinical and Experimental Ophthalmology;2021-09-01

5. Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus;Diabetes & Metabolism Journal;2021-05-31